eXoZymes, Inc.
EXOZ · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $72 | $72 | $71 | $68 |
| Gross Profit | -$72 | -$72 | -$71 | -$68 |
| % Margin | – | – | – | – |
| R&D Expenses | $1,217 | $803 | $575 | $630 |
| G&A Expenses | $0 | $1,703 | $1,376 | $0 |
| SG&A Expenses | $1,234 | $1,703 | $1,376 | $1,285 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$30 | -$71 | $0 |
| Operating Expenses | $2,451 | $2,476 | $1,880 | $1,916 |
| Operating Income | -$2,522 | -$2,548 | -$1,951 | -$1,983 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $235 | $188 | $94 | $145 |
| Pre-Tax Income | -$2,287 | -$2,360 | -$1,856 | -$1,838 |
| Tax Expense | $0 | $0 | $0 | -$2 |
| Net Income | -$2,287 | -$2,360 | -$1,856 | -$1,836 |
| % Margin | – | – | – | – |
| EPS | -0.27 | -0.28 | -0.22 | -0.45 |
| % Growth | 3.6% | -27.3% | 51.1% | – |
| EPS Diluted | -0.27 | -0.28 | -0.22 | -0.45 |
| Weighted Avg Shares Out | 8,387 | 8,377 | 8,368 | 8,127 |
| Weighted Avg Shares Out Dil | 8,387 | 8,377 | 8,368 | 8,127 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $77 | $94 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $72 | $72 | $71 | $68 |
| EBITDA | -$2,215 | -$2,288 | -$1,880 | -$1,771 |
| % Margin | – | – | – | – |